Those aspiring to outpace the market meticulously engage in the process of selecting individual stocks. Strategic choices can be instrumental in accelerating your wealth.
Bruker Corp (NASDAQ: BRKR) closed the day trading at $45.36 down -1.39% from the previous closing price of $46.0. In other words, the price has decreased by -$1.39 from its previous closing price. On the day, 1.84 million shares were traded. BRKR stock price reached its highest trading level at $46.375 during the session, while it also had its lowest trading level at $44.9624.
Ratios:
For a better understanding of BRKR, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 0.91 and its Current Ratio is at 1.85. In the meantime, Its Debt-to-Equity ratio is 0.83 whereas as Long-Term Debt/Eq ratio is at 0.82.
Upgrades & Downgrades
In the most recent recommendation for this company, Goldman on December 09, 2025, initiated with a Sell rating and assigned the stock a target price of $40.
On November 20, 2025, Rothschild & Co Redburn started tracking the stock assigning a Buy rating and target price of $60.
Citigroup Downgraded its Buy to Neutral on May 22, 2025, while the target price for the stock was maintained at $40.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Dec 01 ’25 when PACKER RICHARD A sold 5,028 shares for $48.38 per share. The transaction valued at 243,230 led to the insider holds 89,174 shares of the business.
RICHARD A PACKER bought 5,028 shares of BRKR for $243,230 on Dec 01 ’25. On Nov 06 ’25, another insider, ORNELL JOHN A, who serves as the Director of the company, sold 6,233 shares for $39.00 each. As a result, the insider received 243,087 and left with 35,212 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, BRKR now has a Market Capitalization of 6892050944 and an Enterprise Value of 9112633344. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 51.77. For the stock, the TTM Price-to-Sale (P/S) ratio is 2.00 while its Price-to-Book (P/B) ratio in mrq is 2.82. Its current Enterprise Value per Revenue stands at 2.65 whereas that against EBITDA is 15.577.
Stock Price History:
The Beta on a monthly basis for BRKR is 1.17, which has changed by -0.22883487 over the last 52 weeks, in comparison to a change of 0.12529528 over the same period for the S&P500. Over the past 52 weeks, BRKR has reached a high of $64.64, while it has fallen to a 52-week low of $28.53. The 50-Day Moving Average of the stock is 11.37%, while the 200-Day Moving Average is calculated to be 15.87%.
Shares Statistics:
Over the past 3-months, BRKR traded about 3.17M shares per day on average, while over the past 10 days, BRKR traded about 2260840 shares per day. A total of 151.39M shares are outstanding, with a floating share count of 103.19M. Insiders hold about 32.08% of the company’s shares, while institutions hold 88.64% stake in the company. Shares short for BRKR as of 1763078400 were 13424506 with a Short Ratio of 4.23, compared to 1760486400 on 13347504. Therefore, it implies a Short% of Shares Outstanding of 13424506 and a Short% of Float of 19.02.
Dividends & Splits
BRKR’s forward annual dividend rate is 0.20, up from 0.2 a year ago. Against a Trailing Annual Dividend Yield of 0.0043478264. The stock’s 5-year Average Dividend Yield is 0.31.
Earnings Estimates
Currently, 13.0 analysts are dedicated to thoroughly evaluating and rating the performance of Bruker Corp (BRKR) in the stock market.The consensus estimate for the next quarter is $0.42, with high estimates of $0.61 and low estimates of $0.26.
Analysts are recommending an EPS of between $1.9 and $1.86 for the fiscal current year, implying an average EPS of $1.88. EPS for the following year is $2.15, with 15.0 analysts recommending between $2.44 and $2.0.
Revenue Estimates
12 analysts predict $958.27M in revenue for. The current quarter. It ranges from a high estimate of $966.5M to a low estimate of $952.51M. As of. The current estimate, Bruker Corp’s year-ago sales were $979.6MFor the next quarter, 12 analysts are estimating revenue of $803.42M. There is a high estimate of $828.43M for the next quarter, whereas the lowest estimate is $766.8M.
A total of 13 analysts have provided revenue estimates for BRKR’s current fiscal year. The highest revenue estimate was $3.43B, while the lowest revenue estimate was $3.41B, resulting in an average revenue estimate of $3.42B. In the same quarter a year ago, actual revenue was $3.37BBased on 13 analysts’ estimates, the company’s revenue will be $3.47B in the next fiscal year. The high estimate is $3.55B and the low estimate is $3.43B.
